Inhibitor Therapeutics INTI
OTC INTI
$0.11 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

Inhibitor Therapeutics (INTI) Interest Coverage Ratio (2014 - 2022)

Updated

Inhibitor Therapeutics' (INTI) Interest Coverage Ratio stood at -126.23 in Q4 2022.

Analysis

Inhibitor Therapeutics (INTI) Interest Coverage Ratio (2014 - 2022) Analysis & Trends

For FY2022, Inhibitor Therapeutics' Interest Coverage Ratio came in at -28.32.

  • Across earlier years, Interest Coverage Ratio came in at -21.93 in FY2021.
  • The Q4 2022 figure is the lowest quarterly Interest Coverage Ratio since Q4 2014.
  • Per Business Quant, the preceding three quarters came in at -9.08 (Q3 2022), -10.47 (Q2 2022) and -17.28 (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 25.41
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 10.28
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 7.27
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 5.22
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -42.08
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Inhibitor Therapeutics 19.12 Mn 11.93 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -126.23
Sep 30, 2022 -9.08
Jun 30, 2022 -10.47
Mar 31, 2022 -17.28
Dec 31, 2014 -944.35
Sep 30, 2014 -372.96
Jun 30, 2014 -84.65
Mar 31, 2014 -19.56
API Access

Inhibitor Therapeutics Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=INTI&period=max&api_key=YOUR_API_KEY